[Clinical study for the evaluation of the tolerability of O-(beta-hydroxy-ethyl)-rutoside in the treatment of hemorrhoids during the 3d trimester of pregnancy and in the postpartum period].
Hemorrhoidal disease is particularly frequent in the last trimester of pregnancy and immediately after birth. The aim of the present study was to evaluate the efficacy and tolerability of high doses of O-(beta-hydroxyethyl)-rutoside in patients affected by this pathology. Forty-two women with hemorrhoid varices of varying severity which had appeared during the last trimester of pregnancy or immediately post-partum were treated by administering 3 g/day of the substance in question for 14 consecutive days. At the start and end of treatment a series of clinical and objective parameters were measured and at the end of treatment efficacy and tolerability were assessed. The latter was found to be excellent; in fact, it was not necessary to suspend treatment in any of the subjects treated. Clinical efficacy, assessed by the researcher, was judged to be positive in 95% of cases treated. Clinical improvements in the parameters examined were statistically significant (p < 0.01). The results obtained confirm the value of oral therapy using O-(beta-hydroxyethyl)-rutoside in pregnant or puerperal patients since the preparation was found to be efficacious and easily managed, above all significantly reducing pain, subjectively the most urgent symptom to be treated.
Benzi
G
G
II Clinica Ostetrico-Ginecologica, Università degli Studi di Milano.
Vanzulli
A
A
Pozzi
E
E
Acerboni
S
S
D000328:Adult; D005260:Female; D006484:Hemorrhoids / Q000188:drug therapy*; D006801:Humans; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy*; D011263:Pregnancy Trimester, Third; D011644:Puerperal Disorders / Q000188:drug therapy*; D012431:Rutin / Q000031:analogs & derivatives* / Q000627:therapeutic use
C056067:rutin sulfate; D012431:Rutin
Studio clinico per la valutazione e la tollerabilità di O-(beta-idrossietil)-rutosidea nel trattamento della malattia emorroidaria comparsa nel III trimestre di gravidanza e nel post-partum.